TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/20/23 18:56 | 7/18/23 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | S.d | -11 | 16.00 | 0 | -1 | 0 | 3,850 | D | |||||||||||||||
7/20/23 18:56 | 7/18/23 | SGMT | Sagimet Biosciences Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | P.d | 480 | 16.00 | 0 | 30 | 1 | 3,850 | D | |||||||||||||||
2/10/23 21:25 | 2/9/23 | UTRS | Minerva Surgical Inc | DE | Health | MdEq | Surgical & Medical Instrument | New Enterprise Associates 13 LP | MD | T | P | 5,000 | 0.2046 | 0 | 24,438 | 244 | 34,437 | D | |||||||||||||||
10/26/22 16:41 | 10/25/22 | PHAS | Phasebio Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | S | -262 | 0.1470 | 0 | -1,784 | -27 | 4,858 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |